Leerink Partnrs Predicts Increased Earnings for Danaher

Danaher Co. (NYSE:DHR) – Equities research analysts at Leerink Partnrs increased their FY2024 EPS estimates for Danaher in a report released on Tuesday, January 21st. Leerink Partnrs analyst P. Souda now expects that the conglomerate will post earnings of $7.52 per share for the year, up from their prior forecast of $7.49. The consensus estimate for Danaher’s current full-year earnings is $7.49 per share. Leerink Partnrs also issued estimates for Danaher’s Q4 2024 earnings at $2.18 EPS.

A number of other research firms have also recently issued reports on DHR. Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective for the company in a report on Thursday, October 31st. Guggenheim assumed coverage on shares of Danaher in a report on Thursday, December 19th. They issued a “buy” rating and a $275.00 price target on the stock. UBS Group reduced their price target on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research note on Wednesday, October 23rd. Evercore ISI upped their target price on shares of Danaher from $275.00 to $278.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 1st. Finally, Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price on the stock in a research report on Friday, December 13th. Six investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $285.55.

Danaher Stock Up 0.0 %

Shares of NYSE:DHR opened at $244.19 on Wednesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The business has a 50 day simple moving average of $234.84 and a two-hundred day simple moving average of $253.53. Danaher has a 1 year low of $225.42 and a 1 year high of $281.70. The firm has a market capitalization of $176.38 billion, a PE ratio of 46.60, a price-to-earnings-growth ratio of 4.30 and a beta of 0.83.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating the consensus estimate of $1.57 by $0.14. The company had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. During the same period in the prior year, the firm posted $2.02 EPS. The firm’s revenue was up 3.1% compared to the same quarter last year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be paid a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. Danaher’s payout ratio is 20.61%.

Hedge Funds Weigh In On Danaher

Hedge funds and other institutional investors have recently modified their holdings of the stock. Coronation Fund Managers Ltd. lifted its holdings in shares of Danaher by 29.9% during the second quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock worth $1,596,000 after purchasing an additional 1,470 shares during the period. ProShare Advisors LLC lifted its stake in Danaher by 7.9% during the 2nd quarter. ProShare Advisors LLC now owns 96,531 shares of the conglomerate’s stock valued at $24,118,000 after acquiring an additional 7,091 shares during the period. Mount Yale Investment Advisors LLC boosted its holdings in shares of Danaher by 43.8% in the 2nd quarter. Mount Yale Investment Advisors LLC now owns 2,641 shares of the conglomerate’s stock valued at $660,000 after acquiring an additional 805 shares during the last quarter. EverSource Wealth Advisors LLC increased its stake in shares of Danaher by 12.1% in the second quarter. EverSource Wealth Advisors LLC now owns 1,531 shares of the conglomerate’s stock worth $424,000 after acquiring an additional 165 shares during the period. Finally, DRW Securities LLC purchased a new position in shares of Danaher during the second quarter worth $385,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.